Toro Corp. TORO 深 沪
已收盘 08-07 16:00:00 美东时间
5.52
+0.190
+3.56%
华盛通- 最 高5.64
- 今 开5.33
- 成交量 1.94万股
- 最 低 5.06
- 昨 收 5.33
- 总市值 0
- 52周最高 8.4999
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 2.6398
- 委 比 -60.00%
- 总股本 --
- 历史最高 8.4999
- 量 比 0.76
- 振 幅 10.88%
- 历史最低 1.10
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alpha Buying: When Insiders Buy Into Chaos
There is a reason seasoned investors stop what they are doing when insiders sta...
04-30 23:14
12 Industrials Stocks Moving In Monday's Pre-Market Session
Gainers High-Trend International (NASDAQ:HTCO) stock increased by 21.4% to $13...
04-27 20:05
Toro Q3 EPS $0.01 Up From $(0.01) YoY, Sales $5.377M Up From $5.318M YoY
Toro (NASDAQ:TORO) reported quarterly earnings of $0.01 per share. This is a 211.11 percent increase over losses of $(0.01) per share from the same period last year. The company reported $5.377 million in sales this
2025-12-05 21:58
Toro Corp. Announces Vessel Acquisition
Toro Corp. has agreed to acquire a 2021-built MR tanker vessel for $36.25 million, to be funded with cash on hand, with delivery expected in Q2-Q3 2025. The acquisition will expand the company's fleet to four LPG carriers and one MR tanker vessel.
2025-06-11 13:00
Johnson & Johnson Announces Health Canada Authorizes LAZCLUZE In Combination With RYBREVANT As A First-Line Chemotherapy-Free Treatment For Patients With EGFR-Mutated Advanced Lung Cancer
Phase 3 MARIPOSA study showed LAZCLUZE® plus RYBREVANT® significantly improved progression-free survival, reducing the risk of disease progression or death by 30 per cent versus osimertinib alone.1TORONTO,
2025-03-10 20:46
